|
@@ -0,0 +1,65 @@
|
|
|
+# Metadata for DOI registration according to DataCite Metadata Schema 4.1.
|
|
|
+# For detailed schema description see https://doi.org/10.5438/0014
|
|
|
+
|
|
|
+## Required fields
|
|
|
+
|
|
|
+# The main researchers involved. Include digital identifier (e.g., ORCID)
|
|
|
+# if possible, including the prefix to indicate its type.
|
|
|
+authors:
|
|
|
+ -
|
|
|
+ firstname: "Sampath K.T"
|
|
|
+ lastname: "Kapanaiah"
|
|
|
+ affiliation: "Institute for Applied Physiology, Ulm University, Germany"
|
|
|
+ -
|
|
|
+ firstname: "Holger"
|
|
|
+ lastname: "Rosenbrock"
|
|
|
+ affiliation: "Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Germany, Biberach an der Riss, Germany"
|
|
|
+ -
|
|
|
+ firstname: "Bastian"
|
|
|
+ lastname: "Hengerer"
|
|
|
+ affiliation: "Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Germany, Biberach an der Riss, Germany"
|
|
|
+ -
|
|
|
+ firstname: "Dennis"
|
|
|
+ lastname: "Kaetzel"
|
|
|
+ affiliation: "Institute for Applied Physiology, Ulm University, Germany"
|
|
|
+
|
|
|
+# A title to describe the published resource.
|
|
|
+title: "Neural effects of dopaminergic compounds revealed by multi-site electrophysiology in mice and interpretable machine-learning"
|
|
|
+
|
|
|
+# Additional information about the resource, e.g., a brief abstract.
|
|
|
+description: |
|
|
|
+ The LFP_RawData folder contains local field potential (LFP) recordings obtained from depth electrodes in the mice brain regions,
|
|
|
+ including the prelimbic cortex (PrL), mediodorsal thalamus (MD), dorsal hippocampal fissure (dCA1),
|
|
|
+ dorsal hippocampal CA3 subfield (dCA3), and ventral hippocampal fissure (vHC).
|
|
|
+ Pharmaco-LFP experiments were conducted approximately every third day in a within-subject design with a latin-square,
|
|
|
+ randomized drug-assignment across the cohort. Applications included: saline (Sal; vehicle 1),
|
|
|
+ 0.1% TWEEN80/saline (T/Sal; vehicle 2), 1 and 3 mg/kg clozapine (CLZ1 and CLZ3; clozapine dihydrochloride, HB6129, HelloBio, GB),
|
|
|
+ 0.5 mg/kg raclopride (Raclo; S(-)raclopride(+)-tartrate, R121 Sigma, DE), 0.1 mg/kg SCH23390 (SCH; SCH23390 hydrochloride, 0925 Tocris, GB),
|
|
|
+ and 2 mg/kg amphetamine (Amph; d-amphetamine sulfate, A-5880, Sigma); vehicle 2 was used for raclopride,
|
|
|
+ all other compounds were applied in saline.
|
|
|
+ Mice were recorded in Type-III open-field cages (Tecniplast, IT) with fresh saw-dust for a 10 min baseline period,
|
|
|
+ after which the compound was applied i.p., followed by a further recording for 50 min.
|
|
|
+
|
|
|
+# Lit of keywords the resource should be associated with.
|
|
|
+# Give as many keywords as possible, to make the resource findable.
|
|
|
+keywords:
|
|
|
+ - Neuroscience
|
|
|
+ - Antipsychotics
|
|
|
+ - Neural connectivity
|
|
|
+ - Granger causality
|
|
|
+ - Power spectral density
|
|
|
+ - Electrophysiology
|
|
|
+ - Pharmaco-EEG
|
|
|
+ - Local field potential
|
|
|
+
|
|
|
+# License information for this resource. Please provide the license name and/or a link to the license.
|
|
|
+# Please add also a corresponding LICENSE file to the repository.
|
|
|
+license:
|
|
|
+ name: CC0
|
|
|
+ url: 'http://creativecommons.org/publicdomain/zero/1.0'
|
|
|
+
|
|
|
+# Resource type. Default is Dataset, other possible values are Software, DataPaper, Image, Text.
|
|
|
+resourcetype: Dataset
|
|
|
+
|
|
|
+# Do not edit or remove the following line
|
|
|
+templateversion: 1.2
|